Relapsed Hodgkin lymphoma in PET positive patients

First outcome results from MINDACT breast cancer clinical trial

New investigational targeted therapeutic, entrectinib, shows early promise

Treatment of relapsed myeloma with novel targeted and immune therapies

Integrating multiple omics information in the era of precision oncology

Breast cancer risk prediction models improved by adding multiple biological markers of risk

Physical activity may improve prostate cancer prognosis

Inflammatory microenvironment regulates colorectal cancer progression

Innovations in assessing patient outcomes

Current trials in chronic lymphocytic leukaemia

Chronic lymphocytic leukaemia: Transition to a new era

Multi-target S-DNA increases colorectal cancer screening among previously non-compliant patients